NXTC - NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference | Benzinga
BELTSVILLE, Md., June 20, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies, today announced that it will present and host institutional investor meetings at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
A recording of the webcast will be available on the conference day starting at 7 AM ET through the Investors section of the company's website at www.nextcure.com. The webcast will be available on the website for 30 days.
About NextCure, Inc.
NextCure, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing ...